NCT04458129 Polyethylene Glycol and Intestinal Inflammation in Cystic Fibrosis Status UNKNOWN Phase PHASE2
NCT04451213 Magnetic Resonance Imaging and Neuro-Psychological Testing In Cystic Fibrosis Status COMPLETED Phase NA
NCT04402801 Patient Outcomes of Clinic Transition From Face to Face Encounter to Telemedicine in Cystic Fibrosis Status COMPLETED Phase N/A
NCT04400955 A Study of Web and Tablet-based Interactive Audiometry in Adults With CF Status COMPLETED Phase N/A
NCT04397861 T Cell Memory Fuels the Innate Response in Chronic CF Lung Disease Status COMPLETED Phase N/A
NCT04397809 Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis Status COMPLETED Phase N/A
NCT04395820 Prospective Surveillance of Lung Development During Childhood, Adolescence and Adulthood in Healthy and Patients With Cystic Fibrosis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04378153 Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy Status COMPLETED Phase N/A
NCT04362761 A Study Evaluating the Long-Term Safety of Elexacaftor Combination Therapy Status COMPLETED Phase PHASE3
NCT04354038 Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary Exacerbations Status COMPLETED Phase N/A
NCT04353817 A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes Status COMPLETED Phase PHASE3
NCT04353752 Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs Status COMPLETED Phase N/A
NCT04341532 Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations Status COMPLETED Phase N/A
NCT04335370 Pharmacokinetics of Polymyxin B in Adult Patients With Cystic Fibrosis Status COMPLETED Phase N/A
NCT04320381 Qualitative Understanding of Experiences With the SIMPLIFY Trial Status COMPLETED Phase N/A
NCT04306939 Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study Status SUSPENDED Phase N/A
NCT04302662 Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs Status COMPLETED Phase PHASE2